No More NAFLD- An Update on the Nomenclature and Clinical Management of Steatotic Liver Disease (Live Webinar)
In June of 2023 the AASLD updated the nomenclature for NAFLD to Metabolic dysfunction-Associated Steatotic Liver Disease(MASLD). This session address the changes in nomenclature, provide detail recommendations for screening for advanced fibrosis, and update current management practices.
CME/CE Expiration Date: 2/30/24
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific LIVE presentation.
1. Describe nomenclature change for steatotic liver disease (SLD)
2. Recognize when to screen for MASLD in practice
3. Utilize current MASLD management recommendations
Jared Magee, DO, MPH
- 1.00 AMA PRA Category 1 Credit™The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.